Supernus Pharmaceuticals
SUPN
#4374
Rank
ยฃ1.93 B
Marketcap
ยฃ33.31
Share price
-0.60%
Change (1 day)
35.74%
Change (1 year)

Market capitalization of Supernus Pharmaceuticals (SUPN)

Market cap: ยฃ1.93 Billion

As of June 2026 Supernus Pharmaceuticals has a market cap of ยฃ1.93 Billion. This makes Supernus Pharmaceuticals the world's 4374th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Supernus Pharmaceuticals from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ1.93 B-11.94%
2025ยฃ2.19 B34.21%
2024ยฃ1.63 B31.83%
2023ยฃ1.24 B-22.14%
2022ยฃ1.59 B38.74%
2021ยฃ1.14 B17.73%
2020ยฃ0.97 B2.69%
2019ยฃ0.95 B-30.59%
2018ยฃ1.36 B-9.42%
2017ยฃ1.51 B49.1%
2016ยฃ1.01 B128.1%
2015ยฃ0.44 B93.99%
2014ยฃ0.22 B25.35%
2013ยฃ0.18 B34.54%
2012ยฃ0.13 B

End of Day market cap according to different sources

On Jun 8th, 2026 the market cap of Supernus Pharmaceuticals was reported to be:

ยฃ1.93 Billion
by Nasdaq info icon info icon
ยฃ1.93 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
ยฃ418.55 B 21,547.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ118.05 B 6,006.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ767.47 B 39,594.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ84.98 B 4,295.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
ยฃ1.12 B-41.89%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
ยฃ17.31 B 795.58%๐Ÿ‡บ๐Ÿ‡ธ USA